$UPC News
Last published 4mo ago
- 4mo agoUPCDCOYVRDN4 Sizzling Biotech and Healthcare Companies Reporting Strategic MilestonesGlobeNewswireDENVER, June 29, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – As the second half of 2026 begins, a series of regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives
- 4mo agoUPCUniverse Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent PortfolioGlobeNewswireJi'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in
- 9mo agoUPCUniverse Pharmaceuticals INC Announces Effective Date of Dual-Class Share StructureGlobeNewswireJi'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced
- 1y agoUPCUniverse Pharmaceuticals INC Announces Share ConsolidationGlobeNewswireJiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the
- 1y agoUPCUniverse Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual ReportGlobeNewswireJi'an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the
- 1y agoUPCUniverse Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing RequestGlobeNewswireJi'an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a
- 1y agoUPCUnivest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC)GlobeNewswireNew York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the
- 1y agoUPCUniverse Pharmaceuticals INC Announces $15 Million Registered Direct OfferingGlobeNewswireJiangxi, China, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China today announced that it has
- 1y agoUPCUniverse Pharmaceuticals INC Announces Share ConsolidationGlobeNewswireJiangxi, China, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the
- 2y agoUPCUniverse Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyGlobeNewswireJi'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a
- 2y agoUPCUniverse Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024GlobeNewswireJI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company," "we," "our" and "us") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its
- 2y agoUPCUniverse Pharmaceuticals INC Reports Fiscal Year 2023 Financial ResultsPR NewswireUniverse Pharmaceuticals INC ("Universe Pharmaceuticals" or the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today...
- 3y agoUPCUniverse Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held SharesGlobeNewswireJiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the
- 3y agoUPCUniverse Pharmaceuticals INC Announces Share ConsolidationGlobeNewswireJiangxi, China, July 27, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ:UPC) ("Universe Pharmaceuticals" or the "Company"), a pharmaceutical producer and distributor in China, today announced that the
- 3y agoUPCUniverse Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyGlobeNewswireJi'an, Jiangxi, China, March 07, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a
- 3y agoUPCUniverse Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19GlobeNewswireJi'an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that six varieties of the
- 3y agoUPCUniverse Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswireJi'an, Jiangxi, China, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a
- 4y agoUPCUniverse Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022PR NewswireJI'AN, China, Aug. 16, 2022 /PRNewswire/ -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ende
- 4y agoUPCUniverse Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce PlatformsGlobeNewswireJi'an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement
- 4y agoUPCUniverse Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research CenterGlobeNewswireJi'an, Jiangxi, China, March 22, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company has been authorized as an International Branch (th
- 4y agoUPCUniverse Pharmaceuticals INC Reports Fiscal Year 2021 Financial ResultsGlobeNewswireJi'an, Jiangxi, China, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2021.
- 4y agoUPCUniverse Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese MedicineGlobeNewswireJi'an, Jiangxi, China, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into two strategic cooperation agreemen
- 4y agoUPCUniverse Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese MedicineGlobeNewswireJi'an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement
- 4y agoUPCUniverse Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating OfficerGlobeNewswireJi'an, Jiangxi, China, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointed Mr. Baochang Liu as its Chief Operating
- 4y agoUPCUniverse Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese MedicineGlobeNewswireJi'an, Jiangxi, China, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that on December 1, 2021 the Company entered into a strategic cooper
- 5y agoUPCUniverse Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2021GlobeNewswireJi'an, Jiangxi, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal y
- 5y agoUPCUniverse Pharmaceuticals INC to Announce Unaudited Financial Results for The First Six Months of Fiscal Year 2021 on August 2, 2021GlobeNewswireJi'an, Jiangxi, China, July 30, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that it will release its unaudited financial results for the first s
- 5y agoUPCUniverse Pharmaceuticals INC Hosts Reception for Member of Chinese Academy of Engineering and Expert Group from Tianjin University of Traditional Chinese MedicineGlobeNewswireJi'an, Jiangxi, China, July 26, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced the Company hosted a reception on July 20, 2021 for Mr. Boli Zhang,
- 5y agoUPCUniverse Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.GlobeNewswireJi'an, Jiangxi, China, May 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the "Company") (NASDAQ:UPC), a pharmaceutical producer and distributor in China, today announced that the Company entered into a letter of intent on April 23, 2021 (t
- 5y agoUPCUniverse Pharmaceuticals INC Announces Full Exercise of Underwriter’s Over-Allotment Option in the Public OfferingGlobeNewswireJi’an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the...
- 5y agoUPCUniverse Pharmaceuticals INC Announces Closing of Initial Public OfferingGlobeNewswireJi’an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing...
- 5y agoUPCUniverse Pharmaceuticals INC Announces Pricing and Trading of Initial Public OfferingGlobeNewswireJi’an, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”), a pharmaceutical producer and distributor in China, today announced the pricing of its initial...